These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25168601)

  • 1. Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society.
    Mamas MA; Anderson SG; O'Kane PD; Keavney B; Nolan J; Oldroyd KG; Perera D; Redwood S; Zaman A; Ludman PF; de Belder MA;
    Eur Heart J; 2014 Nov; 35(43):3004-12a. PubMed ID: 25168601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age on the prognostic value of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society.
    Kwok CS; Anderson SG; McAllister KS; Sperrin M; O'Kane PD; Keavney B; Nolan J; Myint PK; Zaman A; Buchan I; Ludman PF; de Belder MA; Mamas MA;
    Catheter Cardiovasc Interv; 2015 May; 85(6):944-51. PubMed ID: 25408308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
    Jackson M; Austin D; Kwok CS; Rashid M; Kontopantelis E; Ludman P; de Belder M; Mamas MA; Zaman A
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):E393-E402. PubMed ID: 29726633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative outcomes after unprotected left main stem percutaneous coronary intervention: a national linked cohort study of 5,065 acute and elective cases from the BCIS Registry (British Cardiovascular Intervention Society).
    Almudarra SS; Gale CP; Baxter PD; Fleming SJ; Brogan RA; Ludman PF; de Belder MA; Curzen NP;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):717-30. PubMed ID: 25060013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late percutaneous coronary intervention prevents left ventricular remodeling and improves clinical outcomes in patients with ST-elevation myocardial infarction.
    Fan Y; Bai X; Chen Y; Shen G; Lu Q; Wan Z; Zhou D; Shen Y; Ma A
    Clin Cardiol; 2015 Feb; 38(2):82-91. PubMed ID: 25649130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial).
    Daneault B; Généreux P; Kirtane AJ; Witzenbichler B; Guagliumi G; Paradis JM; Fahy MP; Mehran R; Stone GW
    Am J Cardiol; 2013 Jan; 111(1):12-20. PubMed ID: 23040595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manual Thrombus Aspiration Is Not Associated With Reduced Mortality in Patients Treated With Primary Percutaneous Coronary Intervention: An Observational Study of 10,929 Patients With ST-Segment Elevation Myocardial Infarction From the London Heart Attack Group.
    Jones DA; Rathod KS; Gallagher S; Jain AK; Kalra SS; Lim P; Crake T; Ozkor M; Rakhit R; Knight CJ; Iqbal MB; Dalby MC; Malik IS; Whitbread M; Mathur A; Redwood S; MacCarthy PA; Weerackody R; Wragg A
    JACC Cardiovasc Interv; 2015 Apr; 8(4):575-84. PubMed ID: 25907084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
    Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry.
    Holroyd EW; Sirker A; Kwok CS; Kontopantelis E; Ludman PF; De Belder MA; Butler R; Cotton J; Zaman A; Mamas MA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1283-1292. PubMed ID: 28683933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Differences in Left Ventricular Function Following Percutaneous Coronary Intervention for First Anterior Wall ST-Segment Elevation Myocardial Infarction.
    Weissler-Snir A; Kornowski R; Sagie A; Vaknin-Assa H; Perl L; Porter A; Lev E; Assali A
    Am J Cardiol; 2014 Nov; 114(10):1473-8. PubMed ID: 25257671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between time to reperfusion and echocardiography assessed left ventricular filling pressure in patients with first ST-segment elevation myocardial infarction undergoing primary coronary intervention.
    Shacham Y; Steinvil A; Leshem-Rubinow E; Ben Assa E; Keren G; Roth A; Topilsky Y
    Cardiol J; 2014; 21(4):357-63. PubMed ID: 24142679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Coronary Intervention for Left Main Coronary Disease in New Zealand: National Linkage Study of Characteristics and In-Hospital Outcomes (ANZACS-QI 38).
    Wang TKM; Kerr A; Kasargod C; Chan D; Cicovic S; Dimalapang E; Webster M; Somaratne J
    Cardiovasc Revasc Med; 2020 May; 21(5):573-579. PubMed ID: 31481307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Risk Percutaneous Coronary Intervention of Native Coronary Arteries Without Mechanical Circulatory Support in Acute Coronary Syndrome Without Cardiogenic Shock.
    Khalid N; Zhang C; Shea C; Shlofmitz E; Chen Y; Musallam A; Case BC; Yerasi C; Hashim H; Rogers T; Ben-Dor I; Bernardo NL; Satler LF; Waksman R
    Am J Cardiol; 2021 Nov; 158():37-44. PubMed ID: 34465454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Myocardial Function, Body Mass Index, and Outcome After ST-Segment-Elevation Myocardial Infarction.
    Joyce E; Hoogslag GE; Kamperidis V; Debonnaire P; Katsanos S; Mertens B; Marsan NA; Bax JJ; Delgado V
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28701527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI).
    Eitel I; Friedenberger J; Fuernau G; Dumjahn A; Desch S; Schuler G; Thiele H
    Clin Res Cardiol; 2011 May; 100(5):425-32. PubMed ID: 21125288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.
    Rashid M; Rushton CA; Kwok CS; Kinnaird T; Kontopantelis E; Olier I; Ludman P; De Belder MA; Nolan J; Mamas MA
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2258-2265. PubMed ID: 29169494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes on bleeding events in ST-elevation myocardial infarction patients after urgent percutaneous coronary intervention: A retrospective cohort study.
    Zhang H; Hu X; Wu Q; Shi B
    Medicine (Baltimore); 2016 Aug; 95(33):e4470. PubMed ID: 27537568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.